[Retracted] The In Vitro Antimicrobial and Antibiofilm Activities of Lysozyme against Gram-Positive Bacteria

Table 5

The OD of LYS, LVX, and their combinations with LZD on the mature biofilms of VREF.

Groups	VREF 11		VREF 12		VREF 13
	Values	Percentage (%)	Values	Percentage (%)	Values	Percentage (%)
Control		100.0		100.0		100.0
LYS		112.8		98.3		91.5
LVX		104.8		93.8		87.3
LZD		61.7		55.1		78.9
A: LZD+LYS		79.3		61.2		78.9
B: LZD+LVX		69.7		53.4		74.6
Comparison between different groups
A1: A and LYS	—	70.3	—	62.3	—	86.2
B1: B and LVX	—	61.8	—	54.3	—	81.5
A2: A and LZD	—	75.6	—	65.3	—	90.3
B2: B and LZD	—	112.9	—	96.9	—	94.6

The values of OD are shown in (SD). The percentage was defined as . VREF 11, VREF 12, and VREF 13 represented three different clinical isolates. , , and compared with the control. VREF: vancomycin-resistant Enterococcus faecium; OD: optical density; MTT: methylthiazolyldiphenyl-tetrazolium bromide; LYS: lysozyme; LVX: levofloxacin; LZD: linezolid; –: not tested.